Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
ED and cardiovascular disease are similar conditions, sharing risk factors such as obesity and diabetes. However, few studies have examined ED as an independent predictor of cardiovascular disease.
It is currently unclear whether common treatments that modify cholesterol and blood pressure affect erectile function. Researchers evaluated this further in a recent study.
While the relationship between erectile dysfunction and cardiovascular disease and CVD-related mortality is known, the association between ED and subclinical CVD remains unclear.
In a recent meta-analysis, researchers sought to determine the prevalence of erectile dysfunction among men with diabetes compared with healthy controls. To see results of the analysis, read more.
